Sharps Tech (STSS) - Company Projected Revenue

Corporate company logo of Sharps Technology (STSS)

Planned sales revenues on the GURU.Markets chart demonstrate a trend where the 0.01 metric indicates the development status for Sharps Technology, Inc. (STSS). Management is currently actively scaling capacities for mass distribution. The product possesses high macro-resilience, although the commercialization stage is constraining financial stability. Innovative self-destructing syringes are creating a protected environment, becoming a mandatory standard for modern medical centers.

sharpstechnology.com - STSS Projected Sales Volume (period 04/28/2023 - 05/28/2026)

Summary analytical data breakdowns for Sharps Tech (STSS)

Summary company analytics:Sharps Technology STSS
Brand item of Sharps Technology, Inc.

This indicator measures market expectations for future revenues, allowing for an assessment of the leading reaction of the asset's fundamental value to changing macroeconomic conditions. By analyzing the trajectory of future sales for Sharps Technology, Inc. (STSS), an investor can identify the scaling potential for the production of protected injection systems, which is critical for forecasting new B2B contracts and the subsequent generation of stable free cash flow.

Key competitors

Company Future Sales Volume ISRG (Intuitive Surgical)|Company Projected Revenue Volume DHR|Company Projected Revenue Becton Dickinson BDX|Company Future Revenue STE|WST: Company Future Sales Volume|BAX - Projected Sales Volume|Masimo Corporation (MASI) - Company Projected Revenue|Company Future Sales Volume stevanatogroup.com|TFX (Teleflex) - Projected Sales Volume|Company Expected Sales Volume Merit Medical Systems, Inc. MMSI|Company Projected Revenue Envista Holdings Corp (NVST)|ICU Medical Inc. - Company Revenue Forecast|DENTSPLY SIRONA Inc. - Company Future Sales Volume|Company Projected Revenue Volume LMAT (lemaitre.com)|ATRC - Company Projected Revenue|Company Future Sales STAAR Surgical Co. STAA|ChromaDex Corp (NAGE) - Company Projected Revenue|ZIMV - Company Future Sales|ANGO (AngioDynamics, Inc.) - Projected Sales Volume|CERS: Company Future Revenue|Projected Sales Volume TKNO|Projected Sales Volume Monogram Technologies Inc. (MGRM)|Company Projected Revenue InfuSystem Holdings, Inc. INFU|Company Future Revenue UTMD|KRMD - Company Projected Revenue|Company Expected Revenue NYXH|Microbot Medical (MBOT) - Company Projected Revenue|PDEX - Company Future Sales|Company Future Sales Volume ZTEK|ELUT: Company Future Revenue|Company Future Sales Volume MLSS (Milestone Scientific)|Company Projected Revenue Volume NXGL|Projected Sales Volume RVP (Retractable Technologies, Inc.)|Harvard Bioscience Inc. (HBIO) - Company Expected Sales Volume|Femasys Corp - Projected Sales Volume|MeihuaMed (MHUA) - Company Future Sales Volume|POAI: Projected Sales Volume|Callan JMB - Company Future Revenue|Company Projected Revenue Atrion|Company Revenue Forecast NURO (NeuroMetrix Inc)